Sellomics and provitro are excited to announce an upcoming webinar and interactive workshop titled "Interactive Tissue Microarray (TMA) Workshop for Target ID/Validation and Biomarkers." The event will take place on July 2, 2024, from 14:00 to 15:30 CET.

This workshop is designed for researchers, clinicians, and professionals in oncology, pathology, and drug development. Participants will gain valuable insights into the latest advancements and techniques in TMA technology, crucial for target identification, validation, and biomarker discovery.

Workshop Highlights:
● Expert Insights: Benefit from the extensive knowledge and experience of provitro AG's top experts in target validation and biomarkers.

● Tips and Tricks: Learn good strategies to increase your sample pool for preclinical studies. Also, discover new techniques to improve research quality.

● Real-world Examples: Explore real-world case studies and user examples showing the impact of TMA in finding and validating targets.

● Interactive Hands-on Session: Join a hands-on session on TMA design. You will apply your new knowledge and get feedback from experts.

Who Should Attend:
● Researchers and scientists in oncology, pathology, and biomedical research
● Clinicians involved in biomarker discovery and validation
● Laboratory managers and technicians seeking to enhance their TMA skills
● Professionals interested in advanced tissue analysis techniques

Event Details:
● Date: July 2, 2024
● Time: 14:00 - 15:30 CET
● Registration: https://www.sellomics.com/event/interactive-tissue-microarray-tma-workshop-for-target-id-validation-and-biomarkers-3/register

Want to enhance your knowledge and skills on TMAs? Secure your spot in this exclusive workshop!

About Sellomics GmbH:
Sellomics GmbH is a Europe-wide provider of innovative solutions for cell biology and drug discovery, such as histology services, human gut models, human and animal biospecimens, liquid handling automation devices, antibodies, ELISAs and molecular biology reagents.. We believe that true innovation is only possible when scientists and suppliers work together to create a shared future. Our mission is to bring innovative research tools and solutions to researchers to help bringing new therapies to patients.

www.sellomics.com

About provitro AG:
Provitro stands for more than ten years of experience in commercialisation of cell culture technologies and tissue microarrays backed up by scientific knowledge and resources of immunohistochemical analyses at the Pathological Institute of Charité Universitätsmedizin Berlin. We have added medical research to our own know-how in biotechnology to create solutions to common problems in life sciences. Provitro's team has raised its sights to the interface between research and development to hammer out brand-new solutions to the benefit of future research projects. These are the hallmarks: competence, vision and sustainability.

www.provitro.com